life science investing BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
BELLUS Health Closes $35M Financing to Support Development of its Lead Drug Candidate BLU-5937 for Chronic Cough
West High Yield Resources Ltd. Fully Endorses Draft Minister's Designation Report on the Record Ridge Critical Minerals Project